Edesa Biotech, Inc.EDSANASDAQ

Revenue (LTM)

Net Income (LTM)

$-7M

-16.5% YoY

Free Cash Flow

$-7M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Revenue	0	0	0	0	0
Gross Profit	-0	-0↑0.5%	-0↓55.2%	-0↓1.4%	-0↑35.9%
Operating Income	-24	-18↑22.4%	-9↑49.8%	-7↑23.9%	-8↓12.8%
Net Income	-13	-18↓31.5%	-8↑52.3%	-6↑26.3%	-7↓16.5%
EBITDA	-13	-17↓31.8%	-8↑53.0%	-6↑26.9%	-7↓18.1%
EPS Diluted	-7.73	-8.37↓8.3%	-2.93↑65.0%	-1.93↑34.1%	-1.27↑34.2%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Cash & Equivalents	8	7↓9.5%	5↓24.4%	1↓80.7%	11↑940.4%
Total Current Assets	12	9↓24.8%	6↓29.2%	2↓74.0%	12↑587.1%
Total Assets	15	12↓20.6%	9↓23.2%	4↓57.1%	14↑254.8%
Total Current Liabilities	1	2↑46.8%	2↓14.9%	2↑0.6%	1↓41.2%
Total Liabilities	2	2↑43.1%	2↓15.7%	2↓0.5%	1↓41.2%
Total Equity	13	9↓28.1%	7↓24.9%	2↓71.9%	12↑528.5%
Total Debt	0	0↓80.9%	0↑398.0%	0↓79.0%	0
Net Debt	-8	-7↑8.6%	-5↑25.5%	-1↑80.7%	-11↓960.7%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Operating Cash Flow	-14	-12↑10.1%	-7↑46.0%	-5↑26.3%	-7↓49.7%
Capital Expenditure	-0	-0↑8.0%	0↑100.1%	0	0
Free Cash Flow	-14	-12↑10.1%	-7↑46.0%	-5↑26.3%	-7↓49.7%
Stock-Based Comp	3	2↓29.3%	1↓44.9%	1↓56.9%	1↑35.7%
Net Change in Cash	1	-1↓219.6%	-2↓131.1%	-4↓150.0%	10↑325.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance